|
|
|
|
Suppliers for
Dapagliflozin propanediol 1-hydrate
|
Properties | | CAS |
960404-48-2 | | Formula |
C21H25ClO6.C3H8O2.H2O |
|
5 Registered suppliers
Molecular formula :C24H33ClO8
More details are to be found here
Description : Dapagliflozin (2S)-1,2-propanediol, hydrate is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2). It is in development for the treatment of type 2 diabetes mellitus (T2DM). It inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. - Molecular Weight :502.98
- Melting Point :74-78°C
- Purity :> 98%
Molecular Formula : C24H35ClO9 Canonical SMILES : CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O
InChI :
InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
InChIKey :
GOADIQFWSVMMRJ-UPGAGZFNSA-N
Solubility :
Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Appearance :
White to Off-white Solid
Storage : Store at -20°C
Synonyms :
Dapagliflozin (2S)-1,2-propanediol, hydrate; Dapagliflozin propylene glycol hydrate; D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1); D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate; (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate; Dapagliflozin (S)-propylene glycol hydrate; Dapagliflozin propanediol monohydrate; Edistride; Farxiga; Forxiga; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-propane-1,2-diol (1:1) monohydrate
More details are to be found here
Description : Dapagliflozin (2S)-1,2-propanediol, hydrate is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2). It is in development for the treatment of type 2 diabetes mellitus (T2DM). It inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. - Molecular Weight :502.98
- Melting Point :74-78°C
- Purity :> 98%
Molecular Formula : C24H35ClO9 Canonical SMILES : CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O
InChI :
InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
InChIKey :
GOADIQFWSVMMRJ-UPGAGZFNSA-N
Solubility :
Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Appearance :
White to Off-white Solid
Storage : Store at -20°C
Synonyms :
Dapagliflozin (2S)-1,2-propanediol, hydrate; Dapagliflozin propylene glycol hydrate; D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1); D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate; (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate; Dapagliflozin (S)-propylene glycol hydrate; Dapagliflozin propanediol monohydrate; Edistride; Farxiga; Forxiga; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-propane-1,2-diol (1:1) monohydrate
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-04-26
|
details
details